Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Statistics

Total Valuation

KRX:002620 has a market cap or net worth of KRW 121.27 billion. The enterprise value is 331.05 billion.

Market Cap	121.27B
Enterprise Value	331.05B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:002620 has 15.35 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	15.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	76.13%
Owned by Institutions (%)	0.03%
Float	2.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.16
PB Ratio	0.28
P/TBV Ratio	0.40
P/FCF Ratio	599.24
P/OCF Ratio	26.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 113.45, with an EV/FCF ratio of 1,635.79.

EV / Earnings	-6.47
EV / Sales	0.42
EV / EBITDA	113.45
EV / EBIT	n/a
EV / FCF	1,635.79

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.35.

Current Ratio	1.08
Quick Ratio	0.73
Debt / Equity	0.35
Debt / EBITDA	53.19
Debt / FCF	766.93
Interest Coverage	-1.26

Financial Efficiency

Return on equity (ROE) is -15.82% and return on invested capital (ROIC) is -1.16%.

Return on Equity (ROE)	-15.82%
Return on Assets (ROA)	-0.79%
Return on Invested Capital (ROIC)	-1.16%
Return on Capital Employed (ROCE)	-2.18%
Revenue Per Employee	22.28B
Profits Per Employee	-1.46B
Employee Count	35
Asset Turnover	0.88
Inventory Turnover	4.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.72% in the last 52 weeks. The beta is 1.07, so KRX:002620's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-19.72%
50-Day Moving Average	7,545.20
200-Day Moving Average	8,382.90
Relative Strength Index (RSI)	54.36
Average Volume (20 Days)	174,870

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:002620 had revenue of KRW 779.82 billion and -51.16 billion in losses. Loss per share was -3,333.00.

Revenue	779.82B
Gross Profit	206.52B
Operating Income	-11.18B
Pretax Income	-61.63B
Net Income	-51.16B
EBITDA	2.92B
EBIT	-11.18B
Loss Per Share	-3,333.00

Balance Sheet

The company has 75.88 billion in cash and 155.21 billion in debt, giving a net cash position of -79.33 billion or -5,167.62 per share.

Cash & Cash Equivalents	75.88B
Total Debt	155.21B
Net Cash	-79.33B
Net Cash Per Share	-5,167.62
Equity (Book Value)	437.40B
Book Value Per Share	19,995.26
Working Capital	31.57B

Cash Flow

In the last 12 months, operating cash flow was 4.54 billion and capital expenditures -4.34 billion, giving a free cash flow of 202.38 million.

Operating Cash Flow	4.54B
Capital Expenditures	-4.34B
Free Cash Flow	202.38M
FCF Per Share	13.18

Margins

Gross margin is 26.48%, with operating and profit margins of -1.43% and -6.56%.

Gross Margin	26.48%
Operating Margin	-1.43%
Pretax Margin	-7.90%
Profit Margin	-6.56%
EBITDA Margin	0.37%
EBIT Margin	-1.43%
FCF Margin	0.03%

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.63%.

Dividend Per Share	50.00
Dividend Yield	0.63%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	0.63%
Earnings Yield	-42.18%
FCF Yield	0.17%

Stock Splits

The last stock split was on April 17, 2006. It was a forward split with a ratio of 10.

Last Split Date	Apr 17, 2006
Split Type	Forward
Split Ratio	10

Scores

KRX:002620 has an Altman Z-Score of 1.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.12
Piotroski F-Score	n/a